La comunidad bacteriana gastrointestinal podría ayudarnos a definir quiénes son más aptos para beneficiarse de las inmunoterapias, las cuales han logrado una eficacia sin precedentes en la lucha contra el cáncer.

Massachusetts Eye and Ear researchers have shown that mifepristone, a drug currently FDA-approved for chemical abortion, prevents the growth of vestibular schwannoma (also known as acoustic neuroma) cells. This sometimes-lethal intracranial tumor typically causes hearing loss and tinnitus. The findings, published online today in Scientific Reports, suggest that mifepristone is a promising drug candidate to be repositioned for the treatment of these tumors.

Source: www.sciencedaily.com